Soleno Therapeutics, Inc. (NASDAQ: SLNO)
$43.6250
-0.8950 ( +0.36% ) 345.2K
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
Market Data
Open
$43.6250
Previous close
$44.5200
Volume
345.2K
Market cap
$1.87B
Day range
$42.6400 - $45.2440
52 week range
$36.6100 - $60.9200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jan 06, 2025 |
| 8-k | 8K-related | 15 | Dec 17, 2024 |
| 8-k | 8K-related | 15 | Nov 26, 2024 |
| 8-k | 8K-related | 16 | Nov 06, 2024 |
| 10-q | Quarterly Reports | 55 | Nov 06, 2024 |
| 4 | Insider transactions | 1 | Oct 03, 2024 |
| 4 | Insider transactions | 1 | Oct 03, 2024 |
| 4 | Insider transactions | 1 | Oct 03, 2024 |
| 4 | Insider transactions | 1 | Oct 03, 2024 |
| 4 | Insider transactions | 1 | Aug 30, 2024 |